FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions

WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy (epinephrine) nasal...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news